| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
MGTX
Meiragtx Holdings
|
May 14, 2026 | BUY |
Strong Buy
+145.6% avg upside
13 analysts
|
$25.00
125.79% Upside
|
-3.6% |
|
EYPT
EyePoint Pharmaceuticals
|
May 07, 2026 | BUY |
Strong Buy
+129.0% avg upside
17 analysts
|
$37.00
174.86% Upside
|
-3.6% |
|
MIRM
Mirum Pharmaceuticals
|
May 07, 2026 | BUY |
Strong Buy
+10.1% avg upside
21 analysts
|
$142.00
35.27% Upside
|
+4.1% |
|
FDMT
4D Molecular Therapeutics
|
May 07, 2026 | BUY |
Strong Buy
+272.4% avg upside
15 analysts
|
$35.00
266.07% Upside
|
-7.8% |
|
UTHR
United Therapeutics
|
May 06, 2026 | BUY |
Buy
-20.4% avg upside
26 analysts
|
$701.00
30.52% Upside
|
-7.6% |
|
VRDN
Viridian Therapeutics
|
May 06, 2026 | BUY |
Strong Buy
+102.9% avg upside
32 analysts
|
$34.00
105.14% Upside
|
-8.2% |
|
OCUL
Ocular Therapeutix
|
May 05, 2026 | BUY |
Strong Buy
+153.7% avg upside
21 analysts
|
$30.00
216.86% Upside
|
-7.4% |
|
RYTM
Rhythm Pharmaceuticals
|
May 05, 2026 | BUY |
Strong Buy
+26.0% avg upside
19 analysts
|
$137.00
40.18% Upside
|
+3.8% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.